Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 4 results for "nirmal bang institutional equities"

Perking up

Ashwin J Punnen City: Mumbai The massive rally that drove the Indian market to record highs, has had a positive rub off on the beaten down real estate stocks. Most realty stocks have made sharp gains during the year, as the sentiments seemed to have improved ... The Financial Chronicle, 3 weeks ago
Money Control

USFDA boost for Biocon: Analyst view on stock and sector

The United States Foods and Drug Administration (USFDA) Oncologic Drugs Advisory Committee (ODAC) has recommended an approval of a biosimilar trastuzumab in the US. Trastuzumab is Biocon and Mylan#39;s biosimilar which is a biosimilar version of Herceptin ...
 Money Control1 month ago

Retail investors should be cautious while investing in market: Rahul Arora

In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on the market and specific stocks and sectors.
 Money Control1 month ago

Positive on pharma; buy Dr Reddys, Cipla, Aurobindo: Rahul Arora

In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities, shared his views on various stocks and sectors.
 Money Control2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less